SCHEMBL19109286

SCHEMBL19109286

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)sc5c7ccccc7c7sc8ccccc8c7c65)cc4)c4ccccc34)cccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.41
▸ PTPN1 P18031 1/20 0.36
▸ CA12 O43570 4/20 0.35
▸ CA1 P00915 4/20 0.35
▸ CA2 P00918 4/20 0.35
▸ CA9 Q16790 4/20 0.35
▸ LIMK1 P53667 3/20 0.34
▸ MCL1 Q07820 1/20 0.33
▸ F9 P00740 1/20 0.33
▸ PRKDC P78527 1/20 0.32
▸ CYP1A1 P04798 2/20 0.32
▸ CYP1B1 Q16678 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ PARP14 Q460N5 1/20 0.32
▸ NQO1 P15559 1/20 0.32
▸ NQO2 P16083 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24342937 0.95 ALOX5 (0.43) ALOX5PTPN1CA12CA1CA2
SCHEMBL17932222 0.94 ALOX5 (0.41) ALOX5PTPN1CA12CA1CA2
SCHEMBL19109287 0.94 ALOX5 (0.39) ALOX5PTPN1CA12CA1CA2
SCHEMBL17945519 0.94 ALOX5 (0.41) ALOX5PTPN1CA12CA1CA2
SCHEMBL19109308 0.94 ALOX5 (0.40) ALOX5PTPN1CA12CA1CA2
SCHEMBL24341774 0.93 ALOX5 (0.40) ALOX5PTPN1CA12CA1CA2
SCHEMBL17932029 0.93 ALOX5 (0.36) ALOX5PTPN1CA12CA1CA2
SCHEMBL17945521 0.92 ALOX5 (0.46) ALOX5CA12CA1CA2CA9
SCHEMBL24343142 0.91 ALOX5 (0.45) ALOX5PTPN1CA12CA1CA2
SCHEMBL17945339 0.90 ALOX5 (0.40) ALOX5PTPN1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 — — US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ALOX5 1871/4885PTPN1 4611/4885CA12 1347/4885
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ALOX5 1871/4885PTPN1 4611/4885CA12 1347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback